Merck KGAA acquires Sigma-Aldrich for $16.7bn
Merck KGAA agreed to acquire life sciences giant Sigma-Aldrich Corp. (manufactures and sells chemicals to the research industry) for $16.7bn in cash, or $140 per share (a 36% premium).
- In Vitro Diagnostics
- Research, Analytical Equipment & Supplies
- Drug Discovery Tools
- Synthesis Technologies, Production Processes
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.